๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics of cyclosporine in heart and lung transplant candidates and recipients with cystic fibrosis and Eisenmenger's syndrome

โœ Scribed by Tan, Keith K C; Trull, Andrew K; Hue, Karen L; Best, Nicola G; Wallwork, John; Higenbottam, Tim W


Book ID
109845296
Publisher
Nature Publishing Group
Year
1993
Tongue
English
Weight
845 KB
Volume
53
Category
Article
ISSN
0009-9236

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Cyclosporin pharmacokinetics in heart-lu
โœ V. T. Tsang; A. Johnston; F. Heritier; N. Leaver; M. E. Hodson; M. Yacoub ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› Springer ๐ŸŒ English โš– 529 KB

Cyclosporin (CsA) is currently the main immunosuppressive agent used in organ transplantation with considerable improvement in graft survival. Oral CsA solution is highly lipophilic, and its bioavailability may be reduced in cystic fibrosis (CF) heart-lung transplant recipients with pancreatic, gas

Relative bioavailability of cyclosporin
โœ K. K. C. Tan; J. A. Uttridge; A. K. Trull; J. Wallwork ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 492 KB

Patients with cystic fibrosis absorb cyclosporin poorly and erratically. We have compared the relative bioavailability of cyclosporin from conventional and microemulsion formulations in 5 adult heart-lung transplant candidates with cystic fibrosis. Relative bioavailability was compared at two dose l

A pharmacokinetic comparison of cyclospo
โœ Hilary Eadon; Marlene Rose; Richard O'Neill; Neil Leaver; Magdi Yacoub ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 483 KB

Pharmacokinetic profiles were obtained for 16 heart or lung recipients following the administration of identical doses of cyclosporin as oral solution and capsules on consecutive days. A comparison of pharmacokinetic parameters (AUC, Cmax, Cmi n and tmax) showed that there were no significant differ